Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0001805688-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | JAZZ | GALA RENEE D | Pres, COO | F - Tax | $122.62 | -3,300 | 59.9K | -5% | -$404.6K | |
| 2025-01-22 | 2025-01-17 | JAZZ | GALA RENEE D | Pres, COO | A - Grant | $0.00 | +7,741 | 63.2K | +14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-17 | F | D | 3,300 | $122.62 | 59,933 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-01-17 | A | A | 7,741 | $0.00 | 63,233 | D | — | — |